Dermatol. praxi. 2021;15(1):19-27 | DOI: 10.36290/der.2021.003

Side effects of acne treatment and their solutions

MUDr. Zuzana Nevoralová, Ph.D.
Akné poradna, Kožní oddělení Nemocnice Jihlava

Acne is a polymorphic inflammatory disease of a piloseboceaus unit. The treatment of acne is divided into local, systemic and a phycical ones. A suitable complementary treatment of acne is necessary. In an article, possible side effects of local and systemic treatment are described. With the local therapy there are only unpleasant but not serious ones. With the peroral therapy side effects can be serious ones. That is why it is necessary before starting each therapy to instruct properly each patient not only about an application (usage) of a medicine but also about possible side effects and about a way how to prevent them or how to minimize them. Side effects have to be explained particular carefully before starting isotretinoin therapy. It is suitable, patients had a possibility to contact their dermatologist at an origin of more serious side effects as soon as possible. Generally, it is beter to prevent or minimize side effects than to let them develop or to stop a treatment.

Keywords: acne, side effects, local treatment, systemic treatment, antibiotics, resistence, isotretinoin.

Published: April 6, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z. Side effects of acne treatment and their solutions. Dermatol. praxi. 2021;15(1):19-27. doi: 10.36290/der.2021.003.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dréno B. What is new in the pathophyziology of acne, an overview. J Eur Acad Dermatol Venereol 2017; 31(Suppl 5): 8-12. Go to original source... Go to PubMed...
    2. Thiboutot TM, Dréno B, Abanmi B, et al. Practical management of acne for clinicians: An international c onsensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2018; 78(2), Suppl 1: S1-S23. Go to original source... Go to PubMed...
    3. Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical Retinoids in Acne Vulgaris: A Systematic Review. Am J Clin Dermatol 2019 Jun; 20(3): 345-365. doi: 10.1007/s40257-019-00423-z.PMID: 30674002 Go to original source... Go to PubMed...
    4. Gollnick HPM, Rizova E, Kligman A, et al. Adapalene in the Treatment of Acne: 5-Year Worldwide Clinical Retrospective. J EurAcad Dermatol Venereol 2001; Suppl 3: 2-67.
    5. Leyden J, Stein‑Gold L, Weiss J. Why Topical Retinoids Are Mainstay of Therapy for Acne. Dermatol Ther 2017 Sep; 7(3): 293-304. Go to original source... Go to PubMed...
    6. Schulte BC, Wu W, Rosen T. Azelaic acid: evidence- based up‑date on mechanism of action and clinical application. J Drugs Dermatol 2015; 14: 964-968. Go to PubMed...
    7. Dessinioti C, Katsambas A. Propionbacterim acnes and antibacterial resistence in acne. Clin Dermatol. 2017; 35: 163-167. Go to original source... Go to PubMed...
    8. Kircik LH. The role of benzoyl peroxidin the new treatment paradigm for acne. J Drugs Dermatol 2013; 12: 73-76.
    9. Thiboutot DM, Wiss J, Bucko A. Adapalene‑benzoyl peroxide, a fixed‑dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double‑blind, controlled study. J Am Acad Dermatol 2007; 57(5): 791-799. Go to original source... Go to PubMed...
    10. Keating MK. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years. Am J Clin Dermatol 2011 Dec 1; 12(6): 407-420. Go to original source... Go to PubMed...
    11. Nevoralová Z. Léčba acne vulgaris. Postgraduální medicína 2013; 15(2): 209-2016.
    12. Plewig G. Acne Therapy. In: Plewig G, Melnik B, Chen, W: Plewig and Kligman's Acne and Rosacea. ISBN 978-3-319-49274-2 (eBook). 4rd ed. Springer Natur Switzerland AG 2019: 225-226. Go to original source... Go to PubMed...
    13. Nast A, Rosumeck S, Dessler C, et al. Antibiotic resistence in acne. Lancet Infect DiS. 2016; 16: 775-777. Go to original source... Go to PubMed...
    14. Thiboutot TM, Dréno B, Abanmi B, et al. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2018; 78(2): Suppl 1: S1-S23. Go to original source... Go to PubMed...
    15. George R, Clarke S, Thiboutot D. Hormonal Therapy for acne Semin Cutan Med Surg. 2008; 27: 188-196. Go to original source... Go to PubMed...
    16. Nast A, Dreno B, Bettoli V, et al. European Evidence‑based (S3) Guidelines for the Treatment of Acne. J Eur Acad Dermatol Venereol 2012; 26(Suppl. 1): 1-29. Go to original source... Go to PubMed...
    17. Nevoralová Z. Izotretinoin v praxi. Mladá fronta 2012.
    18. Curacne - souhrn údajů o přípravku (SPC). Materiál vydaný firmou Pierre Fabre Dermatologie, poslední revize textu 18. 3. 2020.
    19. Cunliffe WJ. The difficult acne patient. Acta Dermatovenerol Croat 2001; 9(3): 183-195.
    20. Sladden MJ, Harman KE. What is the chance of a normal pregnancy in a woman whose fetus has been exposed to isotretinoin? Arch Dermatol 2007; 143(9): 1187-1188. Go to original source... Go to PubMed...
    21. Lasa L, Ayuso‑Mateos JL, Vazques‑Barquero, et al. The use of Beck Depression Inventory to screen for depression in the general population: a prelimitary analysis. J Affect Disord 2000; 57: 261-265. Go to original source... Go to PubMed...
    22. Leyden JJ. The role of isotretinoin in the treatment of acne: personal observationes. J Am Acad Dermatol 1998; 39: S45-S49. Go to original source... Go to PubMed...
    23. Greywal T, Zaenglein AL, Baldwin HE, et al. Evidence‑based recommendations for the management of acne fulminans and its variants. J Am Acad Dermatol 2017; 77(1): 109-117. Go to original source... Go to PubMed...
    24. Roeningk HH, Pinski JB, Robinson JK, et al. Acne, retinoids, and dermabrasion. J Dermatol Surg Oncol 1985; 11: 396-398. Go to original source... Go to PubMed...
    25. Zachariae H. Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment. Br J Dermatol 1988; 118: 705-706. Go to original source... Go to PubMed...
    26. Griffiths WAD. Wound healing and retinoids. Retinoids today and tomorrow 1986; 4: 26.
    27. Cooper AJ, et al. Treatment of acne with isotretinoin: Reccomendations based on Australian experience. Australasian Journal of Dermatology 2003; 44: 97-105. Go to original source... Go to PubMed...
    28. Kaplan G, Haettich B. Rheumatological symptoms due to retinoids. Baillieres Clin Rheumatol 1991; 5(1): 77-99. Go to original source... Go to PubMed...
    29. Charakira A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Ashley Publications Ltd 2004: 119-125. Go to original source...
    30. Mc Carter, TL, Chen YK. Marked Hyperlipidemia and Pancreatitis Associated with Isotretinoin Therapy. Am J Gastroenterol 1992; 87(12): 1855-1857.
    31. Zinkorot 25 mg tbl- souhrn údajů o přípravku (SPC).
    32. Https://www.bioveta.cz/files/files/Humanni‑CZ/Acnevac‑Neo‑text‑PI.
    33. Aravilskaia E, Dreno B. The role of topical dermocosmetics in acne vulgaris. J Am Acad Dermatol 2016; 30: 926-935. Go to original source... Go to PubMed...
    34. Katsambas AD. Improving Compliance with Acne Therapy. In: Zoubolis CC, Katsambas AD, Kligman AM. Pathogebesis and Treatment of Acne and Rosacea. Springer‑Verlag Berlin Heidelberg 2014: 393. Go to original source...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.